Endocrine oncology

Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma

Eur Thyroid JPublished Pooled analysis of genomic studies

Authors' conclusion

Our analysis confirmed that 22qDEL occurs more frequently with RAS point mutations (50.4%), particularly HRAS (70.3%), compared with other PTC drivers (9.3%), supporting the conclusion that 22qDEL is unlikely to be a solitary driver of PTC but possibly an important co-factor in carcinogenesis, particularly in PTCs with RAS driver mutations.

Study context

Population
Primary papillary thyroid carcinoma (PTC) tumors from four published PTC genomic studies
Participants
1,094 primary tumors
Comparison
PTC with 22qDEL vs without 22qDEL
Outcome
Frequency of 22qDEL by driver mutation
Methodological detailspooled analysis of four published PTC genomic studies
  • Pooled analysis of four published PTC genomic studies

Pooled result

As reported in the abstract

PTC with 22qDEL with arm-level loss of heterozygosity
86%

Further pooled results

Differential RNA expression, 22qDEL vs no 22qDEL

Downregulation of most chromosome 22 genes in cases with 22qDEL
Many differentially expressed genes from immune response and regulation pathways

Original publication

Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma. Eur Thyroid J. Published 7 January 2025. doi:10.1530/etj-24-0235

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.